382 related articles for article (PubMed ID: 31817001)
1. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.
Santos-de-Frutos K; Segrelles C; Lorz C
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817001
[TBL] [Abstract][Full Text] [Related]
2. Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer.
Faraji F; Ramirez SI; Anguiano Quiroz PY; Mendez-Molina AN; Gutkind JS
Cells; 2022 Apr; 11(8):. PubMed ID: 35456049
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
[TBL] [Abstract][Full Text] [Related]
5. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
[TBL] [Abstract][Full Text] [Related]
6. Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine.
Ando T; Okamoto K; Shintani T; Yanamoto S; Miyauchi M; Gutkind JS; Kajiya M
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294681
[TBL] [Abstract][Full Text] [Related]
7. EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.
Ando T; Arang N; Wang Z; Costea DE; Feng X; Goto Y; Izumi H; Gilardi M; Ando K; Gutkind JS
Commun Biol; 2021 Nov; 4(1):1237. PubMed ID: 34725466
[TBL] [Abstract][Full Text] [Related]
8. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
[TBL] [Abstract][Full Text] [Related]
9. The Hippo signaling pathway provides novel anti-cancer drug targets.
Bae JS; Kim SM; Lee H
Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
[TBL] [Abstract][Full Text] [Related]
10. The potential role of YAP in head and neck squamous cell carcinoma.
Shin E; Kim J
Exp Mol Med; 2020 Aug; 52(8):1264-1274. PubMed ID: 32859951
[TBL] [Abstract][Full Text] [Related]
11. YAP and WWTR1: New targets for skin cancer treatment.
Andl T; Zhou L; Yang K; Kadekaro AL; Zhang Y
Cancer Lett; 2017 Jun; 396():30-41. PubMed ID: 28279717
[TBL] [Abstract][Full Text] [Related]
12. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
13. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
Front Oncol; 2019; 9():60. PubMed ID: 30805310
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional co-activator YAP: A new player in head and neck cancer.
Segrelles C; Paramio JM; Lorz C
Oral Oncol; 2018 Nov; 86():25-32. PubMed ID: 30409308
[TBL] [Abstract][Full Text] [Related]
15. Hippo Signaling in Cancer: Lessons From
Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M
Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648
[TBL] [Abstract][Full Text] [Related]
16. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms.
Dobrokhotov O; Samsonov M; Sokabe M; Hirata H
Clin Transl Med; 2018 Aug; 7(1):23. PubMed ID: 30101371
[TBL] [Abstract][Full Text] [Related]
17. Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions.
Klaihmon P; Lorthongpanich C; Kheolamai P; Luanpitpong S; Issaragrisil S
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052826
[TBL] [Abstract][Full Text] [Related]
18. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.
Chen N; Golczer G; Ghose S; Lin B; Langenbucher A; Webb J; Bhanot H; Abt NB; Lin D; Varvares M; Sattler M; Egloff AM; Joh R; Uppaluri R; Emerick KS; Lawrence MS; Saladi SV
Cell Rep; 2022 Jun; 39(11):110970. PubMed ID: 35705032
[TBL] [Abstract][Full Text] [Related]
19. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
Boopathy GTK; Hong W
Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
[TBL] [Abstract][Full Text] [Related]
20. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
